Evidence map›Paper›PMID 39958243›Full record

ReviewJournal of clinical and experimental dentistry2025

Effectiveness of mouthwashes to reduce the SARS-COV-2 load in saliva of adults with diagnosis of COVID-19: Systematic review and meta-analysis.

Rosita Elena Espejo-Carrera, Angel Steven Asmat-Abanto, Marcos Jimmy Carruitero-Honores, José Antonio Caballero-Alvarado

Abstract readReview
In one paragraph

Review in Journal of clinical and experimental dentistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rosita Elena Espejo-CarreraMaster's degree in Clinical Research Sciences. Professor of the Posgraduate School, Universidad Privada Antenor Orrego, Trujillo, La Libertad, Peru. Professor of Stomatology Study Program, Universidad Privada Antenor Orrego, Trujillo, La Libertad, Peru.
Angel Steven Asmat-AbantoDoctor in Stomatology, Specialist in Periodontics. Professor of Human Medicine Study Program, Universidad Privada Antenor Orrego, Trujillo, La Libertad, Peru. Professor of Stomatology Study Program, Universidad Privada Antenor Orrego, Trujillo, La Libertad, Peru.
Marcos Jimmy Carruitero-HonoresPostdoctoral Fellow, Specialist in Orthodontics. Professor of Human Medicine Study Program, Universidad Privada Antenor Orrego, Trujillo, La Libertad, Peru.
José Antonio Caballero-AlvaradoDoctor in Clinical and Translational Research, Specialist in General Surgery. Professor of Human Medicine Study Program, Universidad Privada Antenor Orrego, Trujillo, La Libertad, Peru. Professor of Posgraduate School, Universidad Privada Antenor Orrego, Trujillo, La Libertad, Peru. Physician of Surgery Department, Regional Hospital of Trujillo, Trujillo, La Libertad, Peru.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: COVID-19 still represents a threat to public health. In this sense, antiseptic mouthwashes have been suggested to reduce cross-contamination and community transmission. Material and Methods: This systematic review and meta-analysis aimed to synthesize the evidence on the effectiveness of povidone-iodine (PVP-I), cetylpyridinium chloride (CPC) and chlorhexidine (CHX) mouthwashes in reducing SARS-COV-2 viral load in the saliva of adults diagnosed with COVID-19. After the systematic search in five electronic databases, 16 clinical trials published until June 2023 were analyzed. Of these, 6 were included in the meta-analysis. Results: The standardized mean difference (SMD) was reported with its corresponding 95% confidence intervals (95%CI). An overall SMD of 0.51 (95%CI: -0.29 to 1.32; I² = 46.0%; Conclusions: The findings indicate a non-significant effect of mouthwashes on reducing viral load when all types were evaluated together. Separately, only PVP-I showed a significant reduction in viral load with a low level of certainty of evidence, while for CPC and CHX the reduction was not significant, with a low and very low level of certainty of evidence, respectively.

Identifiers

PMID39958243
PMCPMC11829719

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.